" /> Sirtratumab Vedotin - CISMeF





Preferred Label : Sirtratumab Vedotin;

NCIt synonyms : Anti-SLITRK6 Antibody-drug Conjugate AGS15E; Anti-SLITRK6 ADC AGS15E; Anti-SLITRK6 Monoclonal Antibody-MMAE Conjugate AGS15E;

NCIt definition : An antibody-drug conjugate (ADC) composed of sirtratumab, a monoclonal antibody directed against SLIT and NTRK-like protein 6 (SLITRK6), covalently linked to the cytotoxic agent monomethyl auristatin E (MMAE), an auristatin derivative and a potent inhibitor of microtubule polymerization, with potential antineoplastic activity. Upon intravenous administration, the monoclonal antibody moiety of sirtratumab vedotin binds to SLITRK6 expressed on tumor cells, which facilitates both the internalization of the ADC and the intracellular delivery of MMAE. Upon cleavage, MMAE binds to tubulin and inhibits its polymerization, which results in G2/M phase arrest and tumor cell apoptosis. SLITRK6, a member of the Slitrk family of leucine-rich repeat (LRR) neuronal transmembrane proteins, is minimally expressed in normal tissue but overexpressed in a variety of cancers, including bladder cancer, some forms of lung cancer, breast cancer and glioblastoma.;

UNII : E58B6OP5QG;

CAS number : 1824663-83-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1824663-83-3 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : AGS-15E; ASG-15ME;

NCI Metathesaurus CUI : CL553574;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.